Cargando…

Leishmania donovani Infection Enhances Lateral Mobility of Macrophage Membrane Protein Which Is Reversed by Liposomal Cholesterol

BACKGROUND: The protozoan parasite Leishmania donovani (LD) reduces cellular cholesterol of the host possibly for its own benefit. Cholesterol is mostly present in the specialized compartment of the plasma membrane. The relation between mobility of membrane proteins and cholesterol depletion from me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Moumita, Roy, Koushik, Das Mukherjee, Dipanwita, Chakrabarti, Gopal, Roy Choudhury, Kingshuk, Roy, Syamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256160/ https://www.ncbi.nlm.nih.gov/pubmed/25474261 http://dx.doi.org/10.1371/journal.pntd.0003367

Ejemplares similares

Correction: Leishmania donovani Infection Enhances Lateral Mobility of Macrophage Membrane Protein Which Is Reversed by Liposomal Cholesterol
por: Ghosh, Moumita, et al.
Publicado: (2016)

Cholesterol Corrects Altered Conformation of MHC-II Protein in Leishmania donovani Infected Macrophages: Implication in Therapy
por: Roy, Koushik, et al.
Publicado: (2016)

Restoration of IFNγR Subunit Assembly, IFNγ Signaling and Parasite Clearance in Leishmania donovani Infected Macrophages: Role of Membrane Cholesterol
por: Sen, Subha, et al.
Publicado: (2011)

Leishmania donovani Targets Dicer1 to Downregulate miR-122, Lower Serum Cholesterol, and Facilitate Murine Liver Infection
por: Ghosh, June, et al.
Publicado: (2013)

Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
por: Mukherjee, Sandip, et al.
Publicado: (2020)

Modulation of Splenic B Cell Subsets during Experimental Leishmania donovani Infection in BALB/c Mice
por: Mondal, Koushik, et al.
Publicado: (2021)

Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology
por: Forgber, Michael, et al.
Publicado: (2006)

The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice
por: Chowdhury, Sayan, et al.
Publicado: (2012)

Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection
por: Mukherjee, Sandip, et al.
Publicado: (2012)

The role of PD-1 in regulation of macrophage apoptosis and its subversion by Leishmania donovani
por: Roy, Shalini, et al.
Publicado: (2017)

A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
por: Ghosh, Souradeepa, et al.
Publicado: (2021)

Identification of internalin-A-like virulent proteins in Leishmania donovani
por: Mukherjee, Ishita, et al.
Publicado: (2016)

Deletion of Glutamine Synthetase Gene Disrupts the Survivability and Infectivity of Leishmania donovani
por: Kumar, Vinay, et al.
Publicado: (2021)

Antimony Resistant Leishmania donovani but Not Sensitive Ones Drives Greater Frequency of Potent T-Regulatory Cells upon Interaction with Human PBMCs: Role of IL-10 and TGF-β in Early Immune Response
por: Guha, Rajan, et al.
Publicado: (2014)

Leishmania donovani Isolates with Antimony-Resistant but Not -Sensitive Phenotype Inhibit Sodium Antimony Gluconate-Induced Dendritic Cell Activation
por: Haldar, Arun Kumar, et al.
Publicado: (2010)

LEISHMANIA DONOVANI IN THE PERIPHERAL BLOOD
por: Young, Charles W., et al.
Publicado: (1923)

In Vitro Susceptibilities of Wild and Drug Resistant Leishmania donovani Amastigote Stages to Andrographolide Nanoparticle: Role of Vitamin E Derivative TPGS for Nanoparticle Efficacy
por: Mondal, Subhasish, et al.
Publicado: (2013)

Proteomic analysis of the secretome of Leishmania donovani
por: Silverman, J Maxwell, et al.
Publicado: (2008)

Surface antigens of Leishmania donovani promastigotes
Publicado: (1983)

Vaccine Development Against Leishmania donovani
por: Das, Amrita, et al.
Publicado: (2012)

Leishmania donovani bodies in bone marrow
por: Ali, Natasha, et al.
Publicado: (2014)

Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm
por: Roy, Saptarshi, et al.
Publicado: (2016)

Non-Vesicular Lipid Transport Machinery in Leishmania donovani: Functional Implications in Host-Parasite Interaction
por: Das, Koushik, et al.
Publicado: (2023)

ATP independent type IB topoisomerase of Leishmania donovani is stimulated by ATP: an insight into the functional mechanism
por: Sengupta, Souvik, et al.
Publicado: (2011)

Arabinosylated Lipoarabinomannan Skews Th2 Phenotype towards Th1 during Leishmania Infection by Chromatin Modification: Involvement of MAPK Signaling
por: Bhattacharya, Parna, et al.
Publicado: (2011)

Modulation of TLR4 Sialylation Mediated by a Sialidase Neu1 and Impairment of Its Signaling in Leishmania donovani Infected Macrophages
por: Karmakar, Joyshree, et al.
Publicado: (2019)

Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway
por: Mandal, Abhishek, et al.
Publicado: (2016)

Comparative in-silico genome analysis of Leishmania (Leishmania) donovani: A step towards its species specificity
por: S., Satheesh Kumar, et al.
Publicado: (2014)

Development of Quantitative Rapid Isothermal Amplification Assay for Leishmania donovani
por: Khan, Md Anik Ashfaq, et al.
Publicado: (2021)

Retinoic Acid Increases Cellular Cholesterol in Leishmania donovani-Infected Macrophages in an mTOR-Independent Manner
por: Prakash, Satya, et al.
Publicado: (2022)

Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani
por: Duthie, Malcolm S, et al.
Publicado: (2019)

The identification of kala-azar and the discovery of Leishmania donovani.
por: Gibson, M E
Publicado: (1983)

Leishmania donovani and Cutaneous Leishmaniasis, Sri Lanka
por: Siriwardana, H. V. Yamuna D., et al.
Publicado: (2007)

Leishmania donovani Develops Resistance to Drug Combinations
por: García-Hernández, Raquel, et al.
Publicado: (2012)

Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani
por: Morimoto, Ayako, et al.
Publicado: (2016)

On Transient Infections with Leishmania Donovani in Man and Animals
por: Knowles, R., et al.
Publicado: (1924)

Global genome diversity of the Leishmania donovani complex
por: Franssen, Susanne U, et al.
Publicado: (2020)

Development of Derivatives of 3, 3′-Diindolylmethane as Potent Leishmania donovani Bi-Subunit Topoisomerase IB Poisons
por: Roy, Amit, et al.
Publicado: (2011)

The ongoing risk of Leishmania donovani transmission in eastern Nepal: an entomological investigation during the elimination era
por: Roy, Lalita, et al.
Publicado: (2023)

Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B
por: Shadab, Md., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t7hb8t4qii54bf62vprgegdhj5